Compounded Semaglutide
Clinically Studied GLP-1 Therapy for Weight Management
Compounded semaglutide is a GLP-1 receptor agonist prepared by US-licensed 503A pharmacies. Real-world studies of compounded semaglutide demonstrate meaningful weight loss — up to 10.9% at 6 months and 9.11% over 4 months in published observational data. All prescriptions require a medical evaluation by a licensed provider.
Starting at
$147/mo
10.9%
Weight Loss at 6mo*
503A
Licensed Pharmacy
Weekly
Injection
$147
Starting Price/mo
How Compounded Semaglutide Works
A GLP-1 receptor agonist that targets three key pathways to support sustainable weight management
Appetite Regulation
Activates GLP-1 receptors in the hypothalamus to reduce hunger signals and food-seeking behavior, helping patients feel satisfied with smaller portions.
Delayed Gastric Emptying
Slows the rate at which food leaves the stomach, prolonging the sensation of fullness after meals and naturally reducing caloric intake.
Glucose-Dependent Insulin Secretion
Enhances insulin release in response to elevated blood glucose, helping stabilize blood sugar levels and reduce cravings for high-glycemic foods.
Real-World Compounded Semaglutide Data
Published real-world observational studies of compounded semaglutide demonstrate clinically meaningful weight loss outcomes.
5.9%
Weight Loss at 3 Months1
10.9%
Weight Loss at 6 Months1
9.11%
Weight Loss at 4 Months2
1 Ghusn W, et al. (2022). Real-world weight loss outcomes. JAMA Netw Open. PMC9486455.
2 Hasan M, et al. (2024). Compounded semaglutide real-world outcomes. PMC12783696.
Important: Compounded semaglutide is not FDA-approved. The FDA does not review compounded medications for safety, efficacy, or quality. Individual results vary significantly. These observational studies reflect real-world outcomes and are not randomized controlled trials.
Why Choose Compounded?
Real-World Evidence
Published observational studies demonstrate meaningful weight loss with compounded semaglutide in real-world clinical settings.
Appetite Control
Naturally reduces hunger and food-related thoughts so patients feel satisfied with smaller portions.
Weekly Injection
Simple once-weekly subcutaneous injection that fits easily into any routine.
Metabolic Support
Helps regulate blood sugar and insulin sensitivity for comprehensive metabolic health.
Provider-Guided
Gradual dose escalation over 16+ weeks is supervised by a licensed provider who adjusts based on your response.
Combination Options
May be compounded with B6, B12, L-Carnitine, or Glycine for enhanced support (see below).
Semaglutide vs Tirzepatide
Gradual Dose Escalation
Your provider increases your dose every 4 weeks over 16+ weeks to optimize results while minimizing side effects
0.25 mg weekly
Starting dose — body begins adapting to the medication
0.5 mg weekly
First therapeutic dose — noticeable appetite reduction
1.0 mg weekly
Increased efficacy — weight loss accelerates
1.7 mg weekly
Strong therapeutic effect — significant results visible
2.4 mg weekly
Maximum dose — peak efficacy for weight management
Expected Results Timeline
Individual results vary significantly. Your physician will customize dosing based on your response, tolerance, and medical history. Compounded semaglutide is not FDA-approved.
Frequently Asked Questions
Compounded semaglutide contains the same active ingredient (semaglutide) prepared by a US-licensed 503A sterile compounding pharmacy. It is prescribed by a licensed provider after a medical evaluation. Important: Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, efficacy, or manufacturing quality.
Published observational studies of compounded semaglutide show meaningful weight loss. Ghusn et al. (2022, PMC9486455) reported 5.9% weight loss at 3 months and 10.9% at 6 months in 175 patients. Hasan et al. (2024, PMC12783696) reported 9.11% weight loss over 4 months. These are observational studies, not randomized controlled trials, and individual results vary significantly.
Your provider may recommend compounding semaglutide with supportive ingredients: Vitamin B12 (energy support, nausea reduction), Vitamin B6 (protein metabolism, nausea reduction), L-Carnitine (fat oxidation, muscle preservation), or Glycine (antioxidant support, muscle preservation). Your provider will determine the most appropriate formulation based on your medical needs.
The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, and decreased appetite. These are typically mild-to-moderate and often diminish as your body adjusts. The gradual dose escalation protocol helps minimize these effects. Serious side effects are possible — your provider will discuss all risks during your consultation.
Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It should not be used during pregnancy or breastfeeding. Patients with a history of pancreatitis, severe gastrointestinal disease, or certain other conditions may not be candidates. Your provider will conduct a thorough medical evaluation.
Yes. All prescriptions require a medical evaluation by a licensed healthcare provider in your state. The provider will review your medical history, current medications, and health goals to determine if semaglutide is medically appropriate for you. All medical decision-making rests solely with the prescribing provider.
If your provider determines semaglutide is appropriate and writes a prescription, it will be filled by a US-licensed 503A pharmacy and shipped directly to you with appropriate cold-chain handling. Free expedited shipping is included.
Ready to Start Your Weight Management Journey?
Begin with a medical evaluation by a licensed provider. Compounded semaglutide starting at $147/month.
Get Started NowFree medical consultation included • Cancel anytime
Enhanced Formulation Options
Your provider may recommend compounding your GLP medication with one or more supportive ingredients based on your individual medical needs and treatment goals.
Vitamin B12 (Methylcobalamin)
Energy & Nausea Support
Why Your Provider May Recommend It
- Helps reduce nausea — one of the most common GLP-1 side effects
- Maintains energy levels during caloric restriction and weight loss
- Supports nervous system health and neurological function
- Helps prevent B12 deficiency, which is common during rapid weight loss
- Supports metabolic efficiency and red blood cell production
Clinical Context: Vitamin B12 deficiency is common in patients undergoing significant dietary changes. Supplementation during GLP-1 therapy may help maintain energy and reduce gastrointestinal side effects.
Vitamin B6 (Pyridoxine)
Metabolism & Nausea Reduction
Why Your Provider May Recommend It
- Supports protein metabolism during weight loss — helps preserve lean mass
- Aids neurotransmitter synthesis (serotonin, dopamine) for mood support
- Well-established anti-nausea properties (used in pregnancy nausea for decades)
- Supports immune function during caloric restriction
- Helps maintain muscle mass during caloric deficit
Clinical Context: Vitamin B6 has a long history of use for nausea reduction and is FDA-approved for nausea of pregnancy. Its role in protein metabolism makes it particularly relevant during weight loss therapy.
L-Carnitine
Fat Oxidation & Muscle Preservation
Why Your Provider May Recommend It
- Facilitates fatty acid transport into mitochondria for energy production
- Enhances fat oxidation during weight loss — helps the body use fat as fuel
- Supports exercise performance and post-workout recovery
- May improve insulin sensitivity and glucose metabolism
- Helps preserve lean muscle mass during caloric deficit
Clinical Context: L-Carnitine plays a critical role in mitochondrial fatty acid oxidation. During weight loss, enhanced fat oxidation may support more favorable body composition outcomes.
Glycine
Antioxidant & Muscle Preservation
Why Your Provider May Recommend It
- Supports glutathione (GSH) production — the body's master antioxidant
- Helps preserve muscle mass during calorie restriction (Caldow et al., 2016)
- May accelerate fat loss during caloric restriction
- Supports sleep quality and natural growth hormone release
- Anti-inflammatory properties that support overall metabolic health
Clinical Context: Glycine is a conditionally essential amino acid that becomes particularly important during caloric restriction. Its role in glutathione synthesis and muscle preservation makes it relevant for patients on GLP-1 therapy.
Medical Necessity Disclaimer
All combination formulations are determined solely by your prescribing provider based on medical necessity, your individual health profile, current medications, and treatment goals. The information above is provided for educational purposes only and does not constitute medical advice.
Not all patients will benefit from or be candidates for combination formulations. Your provider will evaluate whether any additional ingredients are medically appropriate for your specific situation during your consultation.
All compounded medications are prepared by US-licensed 503A pharmacies in accordance with applicable state and federal regulations. Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, efficacy, or manufacturing quality.
All medical decision-making rests solely with the prescribing provider and/or provider group.